Coffee and tea drinkers had lower risks of dementia and stroke, according to a study published in Plos Medicine in November 2021.
This study involved 365,682 participants aged 50 to 74 years from the UK Biobank.
During an 11.4-year follow-up, 5,079 subjects developed dementia, and 10,053 participants had a stroke.
The researchers found that coffee intake of 2-3 cups a day or tea intake of 3-5 cups a day, or their combined intake of 4-6 cups a day, were linked with the lowest risk of dementia and stroke.
The focus of the investigation was the association, not cause and effect, between coffee and tea consumption with stroke and dementia.
Factors that could influence the outcome, such as weight, diet, and smoking, were controlled.


NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Thailand Inflation Remains Negative for 10th Straight Month in January
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



